clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Separate Studies Show Why Some Prostate Cancers Become Resistant to Hormone…
Informatics
Generative AI Experts Absci Partner with AstraZeneca to Develop Cancer Treatment
News & Features
In Big Obesity Move, Roche Acquires Carmot Therapeutics for $2.7B Up…
News & Features
AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer…
News & Features
Biological Robots Show Healing Potential
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
FDA policy
News & Features
Building T Cell Receptor Therapies with Generative AI
Helen Albert
-
October 18, 2023
0
News & Features
AACR Cancer Progress Report Touts Advances, Advocates Continued Government Research Funding
Chris Anderson
-
September 13, 2023
0
News & Features
Roche’s Alzheimer’s Drug Fails to Shine at Phase III
Helen Albert
-
November 14, 2022
0
News & Features
Regenerative Therapy for Rare Immune Disorder Receives FDA Approval
Helen Albert
-
October 12, 2021
0
Coronavirus
Biodesix, Bio-Rad Pursue FDA EUA Approval for ddPCR-Based COVID-19 Test
Alex Philippidis
-
March 20, 2020
0
Molecular Dx
Beckman Coulter Wins FDA Clearance for Access AMH Immunoassay
Clinical OMICs Staff Writer
-
December 26, 2017
0
Molecular Dx
Foundation One CDx Gets FDA Approval, Concurrent CMS Proposed Coverage Decision
Alex Philippidis
-
December 1, 2017
0
News & Features
FDA Approves Novartis’ Kymriah As First CAR-T Cancer Immunotherapy
Clinical OMICs Staff Writer
-
August 31, 2017
0
News & Features
Snapshot: How to Address the FDA’s Proposed LDT Framework: Moving from CLIA to QSR
Walt Murray
-
September 9, 2016
0
News & Features
FDA Seeks Methods to Better Regulate NGS Products
Jeffrey N. Gibbs
-
September 8, 2016
0
1
2
Page 1 of 2
Related Content
Generative AI Experts Absci Partner with AstraZeneca to Develop Cancer Treatment
AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer and Other Solid Tumors
Large Language Model Identifies Postpartum Hemorrhage
"Ground-Breaking" Release of World’s Largest Whole Genome Resource
Inside Precision Medicine
![Novartis’ Kymriah™ (tisagenlecleucel) will be the first chimeric antigen receptor T-cell (CAR-T) cancer immunotherapy to reach the U.S. following FDA approval yesterday [Source: Novartis]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1229-768x442.jpeg "FDA Approves Novartis’ Kymriah As First CAR-T Cancer Immunotherapy")
